Chronic Hepatitis C

Introduction

A diagnosis of chronic hepatitis C can feel worrying, especially if you have only just learned that the virus has been in your body for some time. You may be wondering how much damage has already been done to your liver, what treatment will involve, and whether the infection can truly be cured.

The reassuring fact is that hepatitis C is now considered one of the most treatable chronic viral infections. Direct-acting antiviral (DAA) tablets, introduced in the mid-2010s, have transformed care. For most people, a course of 8 to 12 weeks of well-tolerated pills clears the virus completely. Major health bodies, including the World Health Organization (WHO), now describe hepatitis C as a curable disease and have set targets for eliminating it as a public health threat.

This guide is written for people who have been told they have chronic hepatitis C, or who are being evaluated for it, and want to understand what comes next. It explains what the infection does to the liver, how it is diagnosed and staged, the treatment options, what to expect during and after therapy, and the long-term monitoring that may be needed — particularly if the liver has already been scarred.

What Is Chronic Hepatitis C?

Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV). When a person is first infected, the immune system clears the virus on its own in roughly one in four cases. In the remaining cases, the virus continues to multiply in the liver cells. If HCV is still detectable in the blood six months after infection, the condition is called chronic hepatitis C.

Chronic hepatitis C often causes no clear symptoms for many years. The virus quietly inflames the liver, and over time this inflammation can lead to fibrosis (scar tissue replacing healthy liver tissue) and eventually cirrhosis (severe, widespread scarring that affects how the liver works). A small proportion of people with long-standing infection also go on to develop liver cancer (hepatocellular carcinoma).

The good news is that treatment can stop, and often reverse, this process. The goal of care is what specialists call sustained virologic response (SVR) — the virus being undetectable in the blood 12 weeks after finishing treatment. SVR is considered a cure. Once it is achieved, the liver usually begins to heal, and the risk of further damage falls sharply, though follow-up may still be needed in people who had advanced scarring before treatment.

HCV Genotypes

The hepatitis C virus exists in several genetic forms, called genotypes, numbered 1 to 6 (with subtypes such as 1a, 1b, 3a). Genotypes differ in how common they are in different parts of the world and, historically, influenced which medications were used. With modern pangenotypic antivirals — drugs that work against all genotypes — the impact of genotype on treatment choice has reduced. Many clinicians still test for it, particularly in people with advanced liver disease or previous treatment failure.

Causes and Risk Factors

Hepatitis C spreads through blood-to-blood contact. The virus enters the bloodstream of one person from the blood of another. Understanding how exposure may have happened helps doctors confirm the diagnosis, plan care, and discuss prevention of future exposure or onward transmission.

How Hepatitis C Is Transmitted

• Sharing needles, syringes, or other equipment used to inject drugs
• Blood transfusions or organ transplants received before routine HCV screening was introduced (in most countries, before the early 1990s)
• Unsafe medical or dental procedures where instruments were not properly sterilised
• Needle-stick injuries, most often in healthcare workers
• Tattooing, body piercing, or cosmetic procedures with unsterilised equipment
• Sharing personal items such as razors or toothbrushes that may carry traces of blood
• Mother-to-child transmission during pregnancy or birth (uncommon, but possible)
• Sexual transmission (uncommon overall, more likely in certain situations such as HIV co-infection or rough sexual contact)

Hepatitis C is not spread by casual contact — sharing meals, hugging, kissing, coughing, sneezing, or using the same toilet does not transmit the virus. Breastfeeding is generally considered safe unless the nipples are cracked and bleeding.

Factors That Affect Disease Progression

Some factors can speed up liver damage in people with chronic hepatitis C, including:

• Regular alcohol use
• Co-infection with hepatitis B or HIV
• Obesity and fatty liver disease
• Diabetes
• Older age at the time of infection
• Male sex (men tend to progress somewhat faster than women)
• Smoking

Signs and Symptoms

Most people with chronic hepatitis C feel well for years and may have no symptoms at all. The infection is often picked up by chance — on a routine blood test, during pregnancy screening, when donating blood, or when liver enzymes are noticed to be raised. This is one reason why many countries now recommend at least one hepatitis C test for all adults.

When Symptoms Do Occur

If symptoms develop, they tend to be vague and non-specific:

• Persistent tiredness or low energy
• Mild discomfort in the upper right side of the abdomen
• Reduced appetite
• Nausea
• Joint or muscle aches
• Difficulty concentrating, sometimes called “brain fog”
• Itchy skin

Signs of Advanced Liver Disease

If chronic infection has caused cirrhosis or significant liver damage, signs become more specific and should always be brought to medical attention:

• Yellowing of the skin or whites of the eyes (jaundice)
• Swelling of the abdomen from fluid build-up (ascites)
• Swelling of the legs or ankles
• Easy bruising or bleeding, including from gums or nosebleeds
• Dark urine and pale stools
• Confusion, drowsiness, or changes in sleep pattern (suggesting hepatic encephalopathy)
• Vomiting blood or passing black, tarry stools (a medical emergency suggesting bleeding from varices)

Symptoms Outside the Liver

Hepatitis C can sometimes affect parts of the body beyond the liver. These are called extrahepatic manifestations and include certain skin rashes, kidney problems, a condition called mixed cryoglobulinaemia, some forms of lymphoma, and links with type 2 diabetes. Successful antiviral treatment often improves or resolves these as well.

Diagnosis

Confirming the Infection

• HCV antibody test: A blood test that looks for antibodies the immune system makes against the virus. A positive result means the person has been exposed to HCV at some point. It does not, on its own, prove that the infection is still active, because antibodies remain even after the virus has been cleared.
• HCV RNA (PCR) test: A test that looks for the genetic material of the virus directly in the blood. If HCV RNA is detected, the infection is active. This is the definitive test for chronic hepatitis C.
• Viral load: The amount of virus in the blood, usually reported as international units per millilitre (IU/mL). Viral load helps confirm active infection and provides a baseline against which treatment response can be compared.
• Genotype testing: Identifies which of the six main HCV genotypes is present. With modern pangenotypic antivirals this is less critical than it once was, but it may still be done.

Assessing the Liver

Once active infection is confirmed, the next step is to find out how the liver is doing.

• Liver function tests: Blood tests measuring enzymes (ALT, AST), bilirubin, albumin, and clotting (INR or prothrombin time). These give a snapshot of how well the liver is working.
• Full blood count and kidney function tests are usually done at the same time.
• Non-invasive fibrosis assessment: Tests that estimate the amount of scarring without needing a biopsy. These include blood-based scores such as APRI and FIB-4, and imaging-based tests such as transient elastography (often known by the brand name FibroScan) or shear wave elastography on ultrasound.
• Ultrasound of the abdomen: Looks at the size and shape of the liver, the spleen, and the blood vessels around them, and screens for signs of cirrhosis or liver cancer.
• CT or MRI scans: Used in selected cases, particularly if cirrhosis is suspected or if a lump is seen on ultrasound.
• Liver biopsy: A small sample of liver tissue taken with a needle, examined under a microscope. Once routine, biopsy is now used much less often, mainly when non-invasive tests give unclear results or another liver disease is suspected alongside hepatitis C.

Screening for Other Infections

Because hepatitis C shares some routes of transmission with other infections, doctors usually test for hepatitis B and HIV at the same time. Vaccination against hepatitis A and hepatitis B may be offered if you are not already immune, because additional liver infections can worsen outcomes.

Treatment

The treatment of chronic hepatitis C has changed dramatically over the past decade. Older regimens based on interferon injections and ribavirin were long, often poorly tolerated, and cured only a fraction of patients. They have been almost entirely replaced by direct-acting antivirals (DAAs) — tablets that target specific steps in the virus’s life cycle and stop it from multiplying.

Current AASLD-IDSA, EASL, and WHO guidance describes DAAs as the standard of care for almost all adults with chronic hepatitis C. Cure rates above 95% are now expected across most patient groups, including people with cirrhosis, kidney disease, HIV co-infection, and previous treatment failure.

How Direct-Acting Antivirals Work

• NS5A inhibitors (for example, ledipasvir, velpatasvir, pibrentasvir, elbasvir)
• NS5B polymerase inhibitors (for example, sofosbuvir)
• NS3/4A protease inhibitors (for example, glecaprevir, grazoprevir, voxilaprevir)

Treatment usually combines drugs from two or three of these classes into a single tablet or a small daily pill burden, so that the virus cannot easily escape by mutating.

Common Regimens

• Sofosbuvir + velpatasvir — a pangenotypic regimen, usually taken once daily for 12 weeks
• Glecaprevir + pibrentasvir — another pangenotypic regimen, often given for 8 weeks in people without cirrhosis
• Sofosbuvir + velpatasvir + voxilaprevir — used mainly as a second-line option after previous DAA treatment did not cure the infection
• Ledipasvir + sofosbuvir, elbasvir + grazoprevir — older but still useful options in certain genotypes

Ribavirin, an older antiviral, is occasionally added to DAA regimens for difficult-to-treat patients, particularly those with decompensated cirrhosis or previous treatment failure.

Who Can Be Treated

Current guidelines from major liver societies recommend treatment for nearly all adults with chronic hepatitis C, regardless of the stage of liver disease. Treatment may be prioritised in people with advanced fibrosis or cirrhosis, those with significant extrahepatic disease, people with HIV or hepatitis B co-infection, and those at risk of transmitting the virus to others (for example, people who are pregnant or planning pregnancy, healthcare workers, or people who share injecting equipment).

What Treatment Involves

For most people, treatment means taking one or two tablets once a day for 8 or 12 weeks. Side effects are usually mild — headache, tiredness, mild nausea, or trouble sleeping. Serious side effects are uncommon with modern regimens. Blood tests are usually done before starting, sometimes during treatment, and again about 12 weeks after the last dose, to check for sustained virologic response.

Drug Interactions and Special Situations

DAAs can interact with several common medicines, including some cholesterol-lowering drugs (statins), heart rhythm drugs (such as amiodarone), some HIV medications, certain anti-seizure drugs, and herbal products such as St John’s wort. It is important to share a complete medication list, including over-the-counter products and supplements, with the team prescribing your treatment.

Special groups — people with advanced cirrhosis, kidney failure, HIV co-infection, hepatitis B co-infection, or those who have had a liver transplant — can usually still be cured, but treatment selection and monitoring are more individualised.

What Happens If the Liver Is Already Damaged

In compensated cirrhosis, the liver is scarred but still managing its essential jobs. DAAs are generally well tolerated, and cure rates remain very high. Long-term surveillance for liver cancer and varices (enlarged veins in the food pipe) is usually continued even after cure.

Decompensated Cirrhosis

In decompensated cirrhosis, the liver can no longer keep up — complications such as fluid in the abdomen, jaundice, bleeding varices, or confusion (encephalopathy) may have already developed. Treatment is still possible but is usually managed in centres with experience in advanced liver disease. Certain DAAs (those containing protease inhibitors) are avoided in this setting. In some cases, hepatitis C is treated before liver transplantation; in others, it is treated after.

Liver Cancer Screening

People with cirrhosis are at higher risk of hepatocellular carcinoma. Major guidelines recommend ongoing surveillance — usually with abdominal ultrasound, sometimes combined with the blood test alpha-fetoprotein (AFP), every six months — even after the virus has been cured.

Lifestyle and Self-Management

While medication does the main work of clearing the virus, day-to-day choices have a real impact on how the liver recovers and on overall health.

Alcohol

Avoiding alcohol is one of the most important steps. Alcohol and HCV together accelerate liver damage, and alcohol use during treatment can interfere with adherence. Major guidelines advise that people with chronic hepatitis C, especially those with fibrosis or cirrhosis, avoid alcohol entirely.

Diet and Weight

There is no single “hepatitis C diet,” but the same principles that protect overall health protect the liver:

• Plenty of vegetables, fruits, whole grains, and legumes
• Adequate protein from lean sources, dairy, eggs, or plant-based foods
• Limiting added sugars and ultra-processed foods
• Limiting saturated fats; using healthier oils in moderation
• Maintaining a healthy body weight, since fatty liver disease worsens hepatitis C outcomes

People with cirrhosis often need specific dietary advice, particularly around salt restriction if there is fluid retention, and adequate protein and calorie intake to prevent muscle loss.

Physical Activity

Regular, moderate exercise — such as brisk walking, cycling, or swimming — helps with energy levels, weight management, and mood. There is no need to avoid normal exercise unless your doctor has advised otherwise because of advanced liver disease.

Medications and Supplements

Some medicines and herbal products can stress the liver or interact with antivirals. Paracetamol (acetaminophen) is generally safer than ibuprofen-type drugs in liver disease, but doses may need to be limited — check with your doctor. Be cautious with herbal liver “tonics,” bodybuilding supplements, and unregulated traditional remedies; some have been linked to liver injury.

Vaccinations

Vaccination against hepatitis A and hepatitis B is generally recommended for people with chronic hepatitis C who are not already immune. Routine vaccines such as those for influenza, COVID-19, and pneumococcal infection are also commonly advised, particularly for people with cirrhosis.

Preventing Transmission to Others

Until the virus is cleared:

• Do not share razors, toothbrushes, nail clippers, or anything that may carry blood
• Cover cuts and grazes with a waterproof dressing
• Tell healthcare and dental staff about your diagnosis, so they can take standard infection-control precautions
• Do not donate blood, organs, tissue, or semen
• For couples, transmission risk through sex is generally low in stable relationships but higher in certain situations; ask your doctor about your individual situation
• If you inject drugs, never share needles or other injecting equipment; harm-reduction services can help

Monitoring During and After Treatment

Monitoring is usually straightforward. Before treatment, baseline blood tests and a fibrosis assessment are done. During the course, simple blood tests may be repeated to check liver enzymes and confirm the virus is being suppressed. The most important test comes 12 weeks after the last tablet: an HCV RNA test to confirm sustained virologic response. If the virus is undetectable at that point, the infection is considered cured.

What Happens After Cure

For people who had little or no liver scarring at the time of treatment, no specific ongoing hepatitis-C-related follow-up is usually needed after cure, although general health checks continue as for anyone else.

For people who had advanced fibrosis (often called F3) or cirrhosis (F4) before treatment, ongoing follow-up is recommended even after cure, because the risk of liver cancer and other complications does not return entirely to baseline. This typically includes:

• Liver ultrasound every six months, sometimes with alpha-fetoprotein
• Periodic endoscopy to look for varices, depending on findings
• Continued attention to alcohol use, weight, diabetes, and other liver stressors

If Treatment Does Not Cure the Infection

A small number of people are not cured by first-line treatment. In that case, specialists usually re-test the virus, sometimes look for resistance-associated changes, and prescribe a different regimen — often a triple-drug combination such as sofosbuvir, velpatasvir, and voxilaprevir. The vast majority of these patients are cured with second-line therapy.

Complications of Untreated Chronic Hepatitis C

• Progressive fibrosis — gradual scarring of the liver over years to decades
• Cirrhosis — advanced, widespread scarring
• Liver failure — the liver can no longer carry out essential functions, leading to jaundice, fluid build-up, bleeding, and confusion
• Portal hypertension — high pressure in the vein that brings blood to the liver, leading to enlarged veins in the food pipe (varices) that can bleed
• Hepatocellular carcinoma — the most common form of primary liver cancer
• Extrahepatic disease — including certain kidney diseases, vasculitis, and some lymphomas

Treatment substantially reduces, though does not always eliminate, these risks, particularly when given before cirrhosis has developed.

Living with Chronic Hepatitis C

For many people, learning they have hepatitis C carries emotional weight as well as medical concern. It is common to feel shock, worry about disclosure, or guilt about how the infection may have been acquired. None of these feelings is unusual, and none reflects a personal failing. Hepatitis C is a virus, not a moral statement, and a large share of infections happen through routes that were not the person’s fault.

Family and Relationships

Routine household contact does not transmit hepatitis C. Family members can share meals, cutlery, and bathrooms safely. Sexual partners of someone newly diagnosed are often advised to be tested, and condoms reduce the already low risk of sexual transmission in many situations. People who are planning pregnancy can usually be treated and cured before conceiving.

Work and Daily Life

Most people with chronic hepatitis C are able to continue working and living normally throughout treatment. Disclosure at work is usually not required, except in a few specific healthcare or surgical roles where rules vary by country and institution.

Mental Health

Fatigue, brain fog, and the stress of diagnosis can affect mood. Depression and anxiety are more common in people with chronic liver disease. Talking to your doctor about these symptoms is worthwhile — they can be treated, and they often improve once the virus is cleared.

Chronic Hepatitis C in Children

Children can have chronic hepatitis C, most often acquired from a mother who had the virus during pregnancy. The course tends to be milder and slower than in adults, but the infection is still important to identify and treat.

Diagnosis in Children

Babies born to mothers with HCV carry maternal antibodies for the first months of life, which can give false-positive antibody tests. Testing is therefore usually done with HCV RNA after a few months of age, or with antibody testing after 18 months. Children who test positive are followed by a paediatric liver specialist.

Treatment in Children

Direct-acting antivirals are now approved for children, with regimens such as sofosbuvir-velpatasvir and glecaprevir-pibrentasvir available for paediatric use down to age 3 in many settings. Cure rates in children mirror those in adults — well over 95% in most studies. Treatment is generally well tolerated, and clearing the virus in childhood is considered beneficial for long-term liver health.

Day-to-Day Considerations

Children with hepatitis C can attend school, play sports, and live normally. Schools do not need to be informed unless a family chooses to. Routine childhood vaccinations are given as usual, and additional hepatitis A and hepatitis B vaccination is generally recommended if not already received.

Prevention

There is currently no vaccine against hepatitis C. Prevention focuses on avoiding blood-to-blood exposure and on identifying and treating people who already have the infection so that the virus does not spread further. Practical steps include:

• Using only sterile, single-use injection equipment
• Ensuring tattoo and piercing studios use single-use needles and properly sterilised equipment
• Safe handling of sharps in healthcare
• Screening of blood and organ donations (now routine in most countries)
• Avoiding sharing personal items that may carry blood
• Harm-reduction services for people who inject drugs, including needle and syringe programmes
• Testing and, where needed, treating sexual partners and household contacts

If you have been cured of hepatitis C, you can be re-infected if exposed again. Continuing to follow these prevention measures protects you and others.

When to Seek Urgent Care

While most people with chronic hepatitis C can take their time planning treatment, certain symptoms warrant urgent medical attention, particularly if cirrhosis has already developed:

• Vomiting blood or passing black, tarry stools
• Sudden, severe abdominal swelling or pain
• New or worsening yellowing of the skin or eyes
• Confusion, severe drowsiness, or difficulty waking
• High fever with abdominal pain in someone with known cirrhosis or ascites
• Severe allergic reaction to a medication (rash, swelling of the face or tongue, difficulty breathing)

Any of these should prompt a same-day visit to an emergency department.

Frequently Asked Questions

Is chronic hepatitis C really curable?

Yes. With modern direct-acting antiviral tablets, sustained virologic response — the virus being undetectable 12 weeks after finishing treatment — is achieved in more than 95% of people across most groups. Sustained virologic response is considered a cure.

How long does treatment take?

Most regimens are 8 or 12 weeks of tablets taken once a day. Some specific situations call for longer treatment or the addition of another medication.

Will I have side effects from the tablets?

Most people tolerate DAAs well. Mild headache, tiredness, nausea, or sleep changes are the most common side effects. Serious side effects are uncommon. Tell your doctor about any new symptoms during treatment.

Can hepatitis C come back after I am cured?

True relapse of the same infection after sustained virologic response is rare. However, the body does not develop lasting immunity, so re-infection from a new exposure is possible. Continuing to avoid blood-to-blood exposure remains important.

Do I still need follow-up after I am cured?

People who did not have advanced fibrosis or cirrhosis before treatment generally do not need ongoing hepatitis-C-specific follow-up. People with advanced fibrosis or cirrhosis continue with liver cancer surveillance and other monitoring, because some risks remain even after the virus is gone.

Can I drink alcohol once I am cured?

Major liver societies advise that anyone with significant fibrosis or cirrhosis avoid alcohol long-term, even after cure. For people with little or no scarring at the time of cure, moderate drinking may be acceptable, but it is worth discussing with the doctor who knows your liver.

Can I have children if I have hepatitis C?

Yes. Hepatitis C does not usually affect fertility. Many people choose to be treated and cured before pregnancy. Mother-to-child transmission during pregnancy or birth is uncommon, and breastfeeding is generally considered safe.

Do I need to tell my family or employer?

Disclosure is a personal decision. Casual contact does not transmit the virus, and most workplaces do not need to know. Some healthcare and surgical roles have specific rules. Telling close household members can help with testing and shared decisions about preventive steps.

Is liver biopsy still needed?

In most cases, no. Non-invasive tests — blood-based scores such as FIB-4 and imaging tests such as transient elastography — have largely replaced biopsy for staging fibrosis. Biopsy is reserved for unclear cases or when another liver condition is suspected.

What if I have hepatitis C and another liver condition, such as fatty liver?

Curing hepatitis C is still important, and treatment works just as well. However, the other condition still needs attention, because untreated fatty liver, alcohol-related disease, or hepatitis B can continue to damage the liver even after HCV is cleared.

Conclusion

Chronic hepatitis C is no longer the lifelong, hard-to-treat illness it once was. A short course of well-tolerated tablets clears the virus in the great majority of people, and the liver typically begins to heal once the infection is gone. For those whose liver was already significantly scarred, treatment slows or stops further damage and lowers the risk of serious complications, although ongoing monitoring remains part of long-term care.

Understanding your diagnosis — what the virus does, how the liver is assessed, what treatment involves, and what follow-up may be needed — puts you in a stronger position to work with your specialist on a plan that fits your situation. With current therapies and steady follow-up, the long-term outlook for people with chronic hepatitis C is, for the first time in the history of the disease, genuinely hopeful.